| |
| |
|
| Insider
Information: |
Perkins Adelene Q |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,196,617 |
|
|
Indirect Shares
|
16,447 |
|
|
| Direct
Value |
$1,726,767 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,213,064 |
|
|
| Total
Value |
$1,726,767 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Infinity Pharmaceuticals Inc |
INFI |
Director |
2023-09-12 |
1,175,291 |
2023-09-12 |
16,447 |
Premium* |
|
|
Bruker Corp |
BRKR |
|
2024-01-05 |
21,326 |
2017-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BRKR |
Bruker Corp |
|
– • – |
2024-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,377 |
21,326 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2023-09-12 |
4 |
AS |
$0.07 |
$28,714 |
D/D |
(410,196) |
1,175,291 |
0 |
% |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2023-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
768,133 |
1,585,487 |
0 |
- |
|
| BRKR |
Bruker Corp |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
18,949 |
0 |
- |
|
| BRKR |
Bruker Corp |
Director |
– • – |
2022-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,841 |
16,979 |
0 |
- |
|
| BRKR |
Bruker Corp |
Director |
– • – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,302 |
15,138 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Executive Officer |
• – – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
155,134 |
793,190 |
0 |
- |
|
| BRKR |
Bruker Corp |
Director |
– • – |
2020-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,472 |
12,836 |
0 |
- |
|
| BRKR |
Bruker Corp |
Director |
– • – |
2019-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,134 |
10,364 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-10-01 |
4 |
AS |
$2.82 |
$14,100 |
D/D |
(5,000) |
609,561 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-03-05 |
4 |
AS |
$2.78 |
$13,890 |
D/D |
(5,000) |
607,252 |
0 |
- |
|
| BRKR |
Bruker Corp |
Director |
– • – |
2018-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,474 |
6,230 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
69,924 |
612,252 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2017-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
85,800 |
535,020 |
0 |
- |
|
| BRKR |
Bruker Corp |
Director |
– • – |
2017-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,756 |
2,756 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2016-10-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
85,800 |
449,220 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2016-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
85,800 |
447,411 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2015-06-25 |
4 |
AS |
$10.93 |
$54,650 |
D/D |
(5,000) |
359,432 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2015-05-27 |
4 |
AS |
$12.81 |
$128,100 |
D/D |
(10,000) |
364,432 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2015-05-14 |
4 |
AS |
$12.18 |
$121,800 |
D/D |
(10,000) |
374,432 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2015-03-16 |
4 |
AS |
$16.00 |
$320,000 |
D/D |
(20,000) |
384,432 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2015-03-05 |
4 |
AS |
$16.50 |
$412,500 |
D/D |
(25,000) |
404,432 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2015-01-29 |
4 |
AS |
$14.83 |
$296,536 |
D/D |
(20,000) |
427,535 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
President & CEO |
• • – |
2015-01-29 |
4/A |
AS |
$14.83 |
$296,536 |
D/D |
(20,000) |
429,432 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Pres & Chief Executive Officer |
• • – |
2013-09-13 |
4 |
AS |
$20.50 |
$268,096 |
D/D |
(13,076) |
447,535 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
